Loading company filing…
Find a company. Follow its revenue through costs and profit.
Coverage includes separate ticker and security records; counts are not unique companies.
Sankey diagram of OLYMPUS CORPORATION. A complete text table follows the diagram.
Surgical & Interventional Solutions is the next-largest disclosed stream in the latest EDINET half-year filing.
Swipe to explore
Every category amount is a reported EDINET XBRL fact. Nodes described as arithmetic bridges are calculated residuals and do not imply a separately reported filing line.
Labels and narrative explain the filing. A category marked “arithmetic bridge” or “residual” is calculated from reported totals, rather than a separately reported line.
| Category | Stage | Value | Notes |
|---|---|---|---|
| Gastrointestinal Solutions | 1 | 307.0B | 67.6% of reported total |
| Surgical & Interventional Solutions | 1 | 147.2B | 32.4% of reported total |
| Other operating segments | 1 | 108M | 0.0% of reported total |
| External customer sales | 2 | 454.4B | Reported six-month total · ¥454.4B |
| Operating profit | 3 | 46.1B | 10.2% operating margin |
| Operating costs & expenses | 3 | 408.2B | Arithmetic residual to reported operating profit |
| Profit before tax | 4 | 44.8B | Reported pretax result |
| Net non-operating cost | 4 | 1.3B | Arithmetic bridge to reported pretax profit |
| Net profit attributable to owners | 5 | 29.2B | Reported parent-company result |
| Tax, attribution & other | 5 | 15.6B | Arithmetic bridge to owners' profit |
| From | To | Value |
|---|---|---|
| Gastrointestinal Solutions | External customer sales | 307.0B |
| Surgical & Interventional Solutions | External customer sales | 147.2B |
| Other operating segments | External customer sales | 108M |
| External customer sales | Operating profit | 46.1B |
| External customer sales | Operating costs & expenses | 408.2B |
| Operating profit | Profit before tax | 44.8B |
| Operating profit | Net non-operating cost | 1.3B |
| Profit before tax | Net profit attributable to owners | 29.2B |
| Profit before tax | Tax, attribution & other | 15.6B |